Voloridge Investment Management, LLC Biogen Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $12.8 Million - $16.1 Million	60,220 New	60,220 $13 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $48.6 Million - $55.4 Million	-189,416 Reduced 99.01%	1,890 $525,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $40.4 Million - $49.1 Million	160,124 Added 513.51%	191,306 $53 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $26.4 Million - $36.4 Million	-135,448 Reduced 81.29%	31,182 $8.33 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $7.72 Million - $9.18 Million	41,162 Added 32.81%	166,630 $34 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $20.1 Million - $25.3 Million	103,805 Added 479.18%	125,468 $26.4 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $9.65 Million - $12.4 Million	-43,090 Reduced 66.55%	21,663 $5.2 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $4.97 Million - $6.48 Million	-17,556 Reduced 21.33%	64,753 $18.3 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $19.9 Million - $31.9 Million	76,806 Added 1395.71%	82,309 $28.5 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1.34 Million - $1.57 Million	5,503 New	5,503 $1.54 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $14.7 Million - $22.1 Million	-62,048 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $45.9 Million - $53 Million	-173,495 Reduced 73.66%	62,048 $17.6 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $47 Million - $62.2 Million	181,679 Added 337.29%	235,543 $63 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $21 Million - $26.6 Million	-78,089 Reduced 59.18%	53,864 $17 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $10.2 Million - $14 Million	46,194 Added 53.86%	131,953 $39.2 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $8.91 Million - $10 Million	-40,987 Reduced 32.34%	85,759 $20 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $26.6 Million - $29.4 Million	121,491 Added 2311.91%	126,746 $29.6 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $573,197 - $896,549	2,645 Added 101.34%	5,255 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $19.7 Million - $24.9 Million	-70,626 Reduced 96.44%	2,610 $785,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $21.5 Million - $28.1 Million	73,236 New	73,236 $25.9 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $5.3 Million - $5.93 Million	-17,217 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $4.84 Million - $5.68 Million	17,217	17,217 $5.39 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account